Melanoma Education: Progress Report
No excerpt…
Melanoma Education: Progress Report
No excerpt…
Peer to Peer Support For The Melanoma Community
No excerpt…
Turn Your Superbowl Party into a Fundraiser for Melanoma Research
No excerpt…
Melanoma VS The Pandemic: Interactive Round-Table Discussions For Health Care Providers
No excerpt…
Taking Steps To End Melanoma
No excerpt…
Volunteer With AIM at Melanoma Form
No excerpt…
Steps Against Melanoma Volunteer Form
…on their feet for four hours and must be able to lift 20 lbs. AIM at Melanoma is seeking volunteers…
FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma
…a subtype of melanoma with mucosal origin. Compared with cutaneous melanoma, mucosal melanoma is less responsive to traditional chemotherapy and…
,
,
Jonathan Swingle, The Mucosal Melanoma Warrior
…never heard the term mucosal melanoma. His lack of knowledge is not surprising, as mucosal melanoma is extremely rare, accounting…
,
Survivor Spotlight: Bev Johnson, Mucosal Melanoma Survivor
…doctor had never seen in her 18 years of practice: vaginal mucosal melanoma. Mucosal melanoma accounts for about 1.4% of…
,
Recent Posts
May. 04, 2026
Melanoma Monday: Every Day. Everywhere.
Apr. 27, 2026
Lilly Pulitzer and AIM at Melanoma Partner for 5th Annual Community Giving Event
Apr. 19, 2026
KIMMTRAK doubles the likelihood of being alive at five years for firstline HLA-A*02:01+ patients with metastatic uveal melanoma
Apr. 10, 2026
FDA Does Not Approve RP1 in Combination with Nivolumab for Advanced Melanoma: What This Means for Patients
Apr. 07, 2026